Jessica P.
Age 31
Height 5'6"
Weight 180 lbs
Lipid Profile:
HDL 40 mg/dL
LDL 165 mg/dL
TG 175 mg/dL
TC 240 mg/dL
 |
|
Previous Patient Profile
Dyslipidemia, BMI 29
Profile and History:
Jessica P. is a 31-year-old homemaker with four children.
- During the complete physical that you performed at her first appointment, you noted that she was somewhat overweight.
Back to top
Diagnosis and Identification:
- She is 5'6" and weighs 180 lbs. Her BMI is 29 and she appears to carry her excess weight around her waist.
- When the blood work came back, your concerns about her weight and its potential impact on her health were confirmed. Her HDL was 40 mg/dL, while her LDL was 165 mg/dL. Her total cholesterol was 240 mg/dL and her triglycerides were 175 mg/dL.
- Despite this lipid profile, lipid-lowering drugs are not prescribed initially (ATPIII). Instead, weight loss and a low-fat diet with increased exercise are considered to improve her dyslipidemic profile and reduce her cardiovascular risk.
More on identifying patients at risk
Back to top
Counseling:
- During the office consultation, Jessica shares your concern and seems motivated to give your plan a try. She tells you, though, that she has tried many diets during her adult years and that she can't seem to stick with them. She thinks it's because she doesn't really see any weight loss in the first months.
- She also has some concerns about how much she can increase her exercise. The kids keep her very busy, but she finds herself spending more and more time driving them from activity to activity.
More on counseling your patient
Back to top
Treatment:
- Treatment goals for Jessica include weight loss, improved lipid profile and reduced cardiovascular risk.
- A prescription for XENICAL plus a reduced-calorie, reduced-fat diet, with each meal planned out over a 2-week period, is appropriate.
- By suggesting that she enroll immediately in the XENICare®
support program, you can ensure that she gets the support she needs
to stick to the routine.
- A recommendation of walking the track at the center where her children take after-school classes is a simple and practical approach to increasing her activity.
More on treatment and management
Back to top
Follow-Up:
Jessica returned to your office and had another blood lipid profile done after 3 months on the plan. She lost 10 pounds and her BMI was down to 27. She tells you that the visits helped her make sure she was sticking to her plan, and when you tell her what her cholesterol level is, she can see the good effects of her efforts.
More on follow-up care
Back to top
Outcomes:
Population with Abnormal (Untreated) Risk Factors at Randomization
Weight Loss with XENICAL Plus Diet: Improved Lipid Levels
- The changes from randomization following 1-year treatment in the population with abnormal lipid levels (LDL >130 mg/dL, LDL/HDL >3.5, HDL <35 mg/dL) were greater for patients on XENICAL plus diet compared to patients on placebo plus diet with respect to LDL cholesterol (-7.83% vs. +1.14%) and the LDL/HDL ratio (-0.64 vs. 0.46). HDL cholesterol increased in the placebo group by 20.1% and in the XENICAL group by 18.8%.
Population as a Whole
XENICAL Plus Diet: Successful Weight Loss
In clinical trials involving 1064 patients, 69% on XENICAL plus diet lost 3% or more of initial body weight within 3 months, with a mean loss of 13 lbs.18
The mean change in total cholesterol was -2.0% for patients on XENICAL plus diet and +5.0% for patients on placebo plus diet. The mean change in LDL cholesterol was
-4.0% for patients on XENICAL plus diet and +5.0% for patients on placebo plus diet. The mean change in HDL cholesterol was +9.3% for patients on XENICAL plus diet and +12.8% for patients on placebo plus diet.
In clinical trials, the overall mean weight loss from randomization to the end of 1 year in the intent-to-treat population was 13.4 lbs in patients treated with XENICAL plus diet versus 5.8 lbs in placebo-treated patients.
Back to top
The long-term effects of orlistat on morbidity and mortality associated with obesity have not been established.
The patient depicted here is fictitious and is intended to illustrate an obesity-related comorbidity for which a treatment regimen including XENICAL plus a reduced-calorie diet is appropriate.
Previous Patient Profile
|
